baber/WOPTO huggingface dataset:
Patent JP-2872810-B2 (JP)
IPC: B29C70/16
Filed: 1993-06-09
Granted: 1999-03-24
Abstract: A fixed-angle centrifuge rotor fabricated from fiber-reinforced composite material includes fibers for reinforcing radially outer portions of the cell holes in a direction transverse to the laminated layers of the rotor core. In one embodiment, the reinforcement fibers are in a reinforcement shell of fiber-reinforced composite material wound over the periphery of the rotor core. In another embodiment, the reinforcement fibers are in a reinforcement cup of fiber-reinforced composite material bonded into each of the cell holes. In a third embodiment, the reinforcement fibers are in a formed region of the laminated layers to orient the fibers therein obliquely to the rotor axis.
Patent JP-H0733397-B2 (JP)
IPC: C07K1/113
Filed: 1986-04-09
Abstract: A composition of matter consisting of recombinant human immune interferon having a near-UV circular dichroic spectrum in aqueous solution at neutral pH with positive bands at about 259 nm, 266 nm, 280 nm, and 287 nm, and with shoulders at about 270 nm and 292 nm. Also disclosed is a method for purifying human immune interferon in which proper refolding of the interferon is accomplished by unfolding in a denaturant, such as urea, dilution in ammonium acetate to approximately 0.18 mg/ml of interferon (or less), and dialysis of the solution. The properly folded, purified product which results has a four- to eight-fold greater activity than the aggregate which otherwise results.
Patent JP-2908880-B2 (JP)
IPC: G01N21/35
Filed: 1994-06-16
Granted: 1999-06-21
Abstract: PCT No. PCT/GB94/01298 Sec. 371 Date Apr. 23, 1996 Sec. 102(e) Date Apr. 23, 1996 PCT Filed Jun. 16, 1994 PCT Pub. No. WO95/00831 PCT Pub. Date Jan. 5, 1995A method of and apparatus for spectrophotometric analysis of a powder material by reflectance measurements of a near infrared beam has a sample cell 2 within which the powder 20A is compressed between a spring biased plate 13 and a window 8 to a predetermined density. Spectrophotometric analysis is effected on the powder 20A through the window 8 by scanning with the infrared beam over an area of the powder 20A which when multiplied by the density of the powder and the depth of penetration of the beam is consistent with a predetermined dosage weight-such as that at which the powder may be marketed.
Patent JP-H0688967-B2 (JP)
IPC: C07D295/073
Filed: 1990-02-27
Abstract: A heterocyclic compound having the structural formula  <IMAGE>  where R is C1-C8 alkyl, C3-C6 cycloalkyl, trifluoromethyl, phenyl, substituted phenyl, phenoxy, substituted phenoxy, benzyl or substituted benzyl; and R1 is at least a partially saturated monocyclic or bicyclic heterocycle of nitrogen which may be substituted with lower alkyl and physiologically acceptable salts thereof is disclosed. A process for forming this compound which involves the reaction of an amine of the formula HR1 where R1 has the meanings given above with a substituted 2-propenyl halide having the structural formula  <IMAGE>  where R has the meanings given above; and X is a halogen atom is described. The invention embodies the above-mentioned novel 2-propenyl halide utilized as an intermediate in the formation of the heterocyclic compound of this invention. A method ofcontrolling phytopathogenic fungi by applying a fungicidally effective amount of the heterocyclic compound of the present invention to the locus under attack by said fungi is also taught. Finally, a fungicidally composition comprising the heterocyclic compound of the present invention and a suitable carrier therefor is set forth.
Patent JP-3225493-B2 (JP)
IPC: G01N33/00
Filed: 1995-07-26
Granted: 2001-11-05
Abstract: Antibodies and fragments thereof which activate an erythropoietin receptor and stimulate erythropiesis are described. Also described are hybridoma cell lines which produce the antibodies and methods and compositions for the treatment of anemia. <IMAGE>
Patent JP-2993022-B2 (JP)
IPC: A61F2/16
Filed: 1989-07-11
Granted: 1999-12-20
Abstract: The invention comprises an IOL with at least a center zone and two concentrically located ring zones arranged thereabout, the center zone having a distance power correction. The first concentric ring zone has a near power correction and the second concentric zone a distance power correction. In one embodiment the lens body is provided with haptics which act to center the lens body when it is surgically implanted within the posterior lens capsule. In other embodiments, the lens diameter is increased to mate with the internal dimensions of the posterior lens capsule or is provided with an encircling haptic which bears against the posterior lens capsule.
Patent JP-2956909-B2 (JP)
IPC: A23D9/00
Filed: 1992-11-06
Granted: 1999-10-04
Abstract: Fully or partially refined marine oil is stabilized by treatment with silica and the incorporation of a lecithin, ascorbyl palmitate and a tocopherol in the thus-treated oil.
Patent JP-3881011-B2 (JP)
IPC: A61P21/00
Filed: 1995-10-24
Granted: 2007-02-14
Abstract: Use of the novel receptor NER TOFA (5-(tetradecyloxy)-2-furan-carboxylic acid) to treat Alzheimer's disease.
Patent JP-3398153-B2 (JP)
IPC: F28F21/08
Filed: 1994-12-21
Granted: 2003-04-21
Abstract: PCT No. PCT/AU94/00784 Sec. 371 Date Aug. 14, 1996 Sec. 102(e) Date Aug. 14, 1996 PCT Filed Dec. 21, 1994 PCT Pub. No. WO95/17642 PCT Pub. Date Jun. 29, 1995The invention provides, in a first form, an expandable plug for regulating pressure or flow within a tube. The plug has an inflatable bladder (12) for diametral expansion by internal fluid pressure introduced by inlet (14). The plug is reinforced by an envelope (26) of cords (28) which spread laterally upon inflation of the bladder to provide diametral support to the bladder. In a second form of the invention, an inflatable plug positioned in a tube of internal diameter d is controlled according to the equation Pp= DELTA P+Pd wherein Pd is the internal pressure in the plug,  DELTA P is the differential pressure across the plug and Pd is the plug free expansion pressure for diameter d.
Patent JP-4020168-B2 (JP)
IPC: A47C27/05
Filed: 1997-09-30
Granted: 2007-12-12
Abstract: Internal mattress wall structures interlockingly engageable with mattress innerspring assemblies provide a structurally integrated resilient mattress support edge to which the mattress padding and upholstery is integrally attached. The wall structures include a main body section with a vertically oriented wall surface and a plurality of parallel flanges which mechanically engage the innerspring assembly by compression fit between the intermediate and terminal convolutions of the perimetrical coils of the innerspring assembly. Corner structures contiguous with side and end wall structures form a contiguous smooth side wall with support characteristics comparable to an innerspring assembly.
Patent JP-3361523-B2 (JP)
IPC: A61K31/565
Filed: 1992-04-14
Granted: 2003-01-07
Abstract: The present invention provides an improved means for regulating the immune response, for ameliorating effects of stress, and for avoiding untoward effects of chemotherapy or exposure to irradiation by administration of androstediol (AED) and androstenetriol (AET). The improved means of regulating immune response can be utilized in treating infectious diseases and immune diseases such as diabetes and chronic fatigue syndrome, both diseases now considered to be immune response related syndromes. These compounds can also be used to treat alopecia, intestinal disorders, immunosuppression induced by steroids, phasyngitis, hemorrhagic conjunctivitis, meningitis, exanthem, encephalitis, hepatitis, infantile, diarrhea, paralysis, pericarditis, myocarditis, diabetes or to increase the immune response against certain anemias or diabetes or to a vaccine immunogen.
Patent JP-3785579-B2 (JP)
IPC: H04N21/4363
Filed: 1996-11-21
Granted: 2006-06-14
Abstract: A home network architecture has an internal digital network interconnecting devices in the home. Entertainment services are introduced into the network through network interface units that are coupled to an external network and to the internal network. The network interface units perform the necessary interfacing between the external and internal networks, and make the entertainment services available to all terminals connected to the internal network. A plurality of set-top electronics that do not have network interface units connect to the internal network and prepare the information in the digital data stream for display, by a television, for example.
Patent JP-4004062-B2 (JP)
IPC: C07K16/00
Filed: 1995-03-09
Granted: 2007-11-07
Abstract: This invention provides therapeutic methods for inhibiting tumor metastasis and for treating primary tumors. The methods of this invention do not cause serious side effects and will be effective for a broad spectrum of cancerous diseases. In particular, the invention discloses a novel method comprising administering to a mammal a preparation of intravenous immunoglobulin (IVIG). The IVIG preparation to be administered according to this invention may contain intact immunoglobulin molecules or fragments of immunoglobulins. The preparation is administered parenterally, preferably via intravenous, intracavitary or subcutaneous routes, either as a sole agent or in combination with other agents or methods which are commonly used for cancer treatment.
Patent JP-3696884-B2 (JP)
IPC: C07D487/04
Filed: 1995-03-27
Granted: 2005-09-21
Abstract: A method of enhancing the efficiency and increasing the duration of action of drugs (e.g. dihydropyridines and anti-bacterials) and particularly of nifedipine and penicillins wherein one or more hydrogen atoms are deuterated and wherein the deuterated drug has unexpectedly improved properties when used in much lower concentrations than unmodified drug. A method for determining the identity and bioequivalency of a new drug is also disclosed wherein the molecular and isotope structure of a new drug is determined by isotope ratio mass spectrometry and compared with the molecular and isotope structure of a known human drug.
Patent JP-4077878-B2 (JP)
IPC: C12R1/19
Filed: 1997-01-31
Granted: 2008-04-23
Abstract: The invention concerns a process for the recombinant production of S-layer proteins in gram-negative host cells. Furthermore the nucleotide sequence of a new S-layer gene and processes for the production of modified S-layer proteins are disclosed.
Patent JP-4267697-B2 (JP)
IPC: A61K31/34
Filed: 1997-02-28
Granted: 2009-05-27
Abstract: Compounds and methods for use in immunosuppressive and anti-inflammatory treatment are described. The compounds are triptolide analogs with improved water solubility and low toxicity.
Patent JP-4301579-B2 (JP)
IPC: C08L3/06
Filed: 1998-01-16
Granted: 2009-07-22
Abstract: Starch is modified with at least one cationic polymer P) and the modified starch is prepared by a process in whicha) an anionically modified starch A) is reacted with a cationic polymer P) orb) a natural starch B) or a starch C) which has not been anionically modified is reacted with the cationic polymer P) in the presence of an anionic modifier M)and the polymer-modified starch is used.
Patent ES-2388863-B2 (ES)
Title: Catalizador de deshidrogenación.
Inventor: CHOI JIN SOON
IPC: B01J23/42
Filed: 2009-05-25
Granted: 2013-08-06
Abstract: Esta invención se relaciona con un catalizador de deshidrogenación que tiene un tamaño de macroporo y una densidad activa alta de platino, adecuado para uso en la deshidrogenación de un gas hidrocarburo. Este catalizador de deshidrogenación que tiene un tamaño de macroporo y una densidad activa alta de platino es altamente activo, tiene densidad activa alta por unidad de área de superficie catalítica, facilita la transferencia de material de reactantes y productos, retrasa la desactivación debido a la formación de coque, mantiene la actividad inicial constante después de ser regenerado gracias al desecho de coque, tiene fuerza alta y por lo tanto es resistente al impacto externo, y no se somete a los cambios estructurales debido al calor ni los cambios en las propiedades de los materiales activos.
Patent ES-2665577-B2 (ES)
Title: Sistema para el ensayo de cargas de fatiga de tracción y compresión sobre los elementos de sujeción de una vía ferroviaria dentro del mismo ciclo de carga
Inventor: CASADO DEL PRADO JOSE ANTONIO
IPC: G01N3/32
Filed: 2017-03-31
Granted: 2018-08-21
Abstract: Sistema para el ensayo de cargas de fatiga de tracción y compresión sobre los elementos de sujeción de una vía ferroviaria dentro del mismo ciclo de carga, que comprende:#- una sección dc carril (21. 31) con una abertura a lo largo del eje longitudinal de su cabeza (22, 32), que presenta a su vez una porción cortada (23);#- traviesas y elementos de sujeción característicos de una vía ferroviaria:#- una barra cilíndrica (24. 44) situada atravesando la abertura de la cabeza (22. 32), de una longitud tal que los extremos de la barra cilíndrica (24. 44) se sitúan fuera de la abertura, y tal que parte de la barra cilíndrica (24. 44) es visible debido a la porción cortada (23);#- una horquilla (25, 45) que comprende un orificio, tal que la barra cilíndrica (24. 44) se sitúa atravesando dicho orificio:#estando el sistema configurado para acoplarse a una máquina de ensayos, por medio de un aplicador (26) permitiendo así la aplicación de fuerzas de tracción y compresión con diferentes grados de inclinación sobre la barra cilíndrica (24, 44). y por ende, sobre el carril (21. 31), las traviesas y los elementos de sujeción de la vía ferroviaria.
Patent ES-2683017-B2 (ES)
Title: Mortero aligerado reforzado con fibras vegetales de caña guadua
Inventor: HERRERO COB ROSA
IPC: C04B18/24
Filed: 2017-03-24
Granted: 2018-12-27
Abstract: La invención prioriza y describe el proceso de obtención de morteros aligerados reforzados mediante la adición de fibras vegetales procedentes de caña guadua (Guadua Angustifolia Kunth) en un porcentaje de hasta un 10%. La versatilidad de este nuevo material permite su uso como mortero de albañilería, como relleno o como producto para la obtención de elementos prefabricados.
Patent IE-S86713-B2 (IE)
Title: Wave energy converter
Inventor: PAUL FRANCIS MCHUGH
IPC: F03B13/00
Filed: 2015-03-10
Abstract: The present invention provides a draught excluder for a sash window, the draught excluder comprising a cover member for securing over a sash cord pulley set into an opening in a side jamb of the window, the cover member having an opening which is closed by a removable closure member, and the removable closure member having an aperture for the passage of the sash cord from the pulley to a counterweight. <Figure 7>
Patent AU-2001259760-B2 (AU)
Title: Method to increase class I presentation of exogenous antigens by human dendritic cells
Inventor: SALGALLER MICHAEL L
IPC: C12N5/0784
Filed: 2001-05-11
Granted: 2006-10-05
Abstract: The present invention relates to a method for increasing the uptake, processing and class I presentation of a soluble antigen by an immature dendritic cells, comprising the steps of: 
a) obtaining a population comprising human immature dendritic cells; 
b) culturing the population immature dendritic cells  in vitro  in a cell culture medium supplemented with a agent that promotes Major-Histocompatability Complex - (MHC-) class I processing and a soluble antigen associated with a tumor cell for a time period sufficient for antigen uptake, processing and presentation, and until maturation of the immature dendritic cells in the population; 
c) separating the soluble tumor antigen and the agent that promotes MHC-class I processing from the mature tumor antigen presenting dendritic cells; and 
d) formulating the mature tumor antigen presenting dendritic cells for administration to a patient.
Patent AU-2001283493-B2 (AU)
Title: DNA vaccines encoding HIV accessory proteins
Inventor: AYYAVOO VELPANDI
IPC: C12N7/01
Filed: 2001-07-12
Granted: 2006-11-30
Abstract: Improved vaccines and methods of using the same are disclosed. Immunosuppressive compositions for treating individuals who have autoimmune diseases or transplants and methods of using the same are disclosed.
Patent AU-2002218253-B2 (AU)
Title: Acylaminoalkyl-substituted benzenesulfonamide derivatives
Inventor: ENGLERT HEINRICH CHRISTIAN
IPC: A61P9/00
Filed: 2001-10-20
Granted: 2006-07-06
Abstract: One embodiment of the present invention relates to acylaminoalkyl-substituted benzenesulfonamide derivatives of the formula (I),in which A, R(1), R(2), X, Y, and Z have the meanings indicated in the specification, and to pharmaceutically tolerable salts thereof. The compounds of the invention are valuable pharmaceutically active compounds that have, for example, an inhibitory action on ATP-sensitive potassium channels in the cardiac muscle and/or in the vagal cardiac nerve and are suitable, for example, for the treatment of disorders of the cardiovascular system such as coronary heart disease, arrhythmias, cardiac insufficiency, cardiomyopathies, decreased contractility of the heart or vagal dysfunction of the heart, or for the prevention of sudden cardiac death. The invention furthermore relates to processes for the preparation of the compounds of the formula (I) and pharmaceutically tolerable salts thereof, their use, and pharmaceutical preparations comprising them.
Patent AU-2002224807-B2 (AU)
Title: Active agent combinations with insecticidal and acaricidal properties
Inventor: ERDELEN CHRISTOPH
IPC: A01N43/38
Filed: 2001-10-29
Granted: 2007-05-24
Abstract: The invention relates to novel active compound combinations having very good insecticidal and acaricidal properties and containing (a) cyclic ketoenols having the formula in which the groups W, X, Y, Z, A, B, D, AND G have the meanings given in the disclosure, and (b) the active compounds (1) to (29) listed in the disclosure.
Patent AU-2002228640-B2 (AU)
Title: Compounds having fungicidal activity and processes to make and use same
Inventor: RIEDER BRENT RIEDER
IPC: C07C317/28
Filed: 2001-11-16
Granted: 2005-11-10
Abstract: A compound according to formula one that is useful as a fungicide is provided. Additionally, processes to make and use same are provided.
Patent AU-2003226682-B2 (AU)
Title: Method for Operating a Milking Facility
Inventor: HOLSCHER FRANK
IPC: A01K1/12
Filed: 2003-03-20
Granted: 2008-09-18
Abstract: Variation of angular position of the milking platform (2) relative to a reference point, is determined by a central unit (8). The location of milking positions (3) is determined.  An Independent claim is included for the corresponding carousel milking plant.
Patent AU-2004281343-B2 (AU)
Title: Overfill protection device
Inventor: EYCK PIET VAN
IPC: F16K31/34
Filed: 2004-10-20
Granted: 2010-04-29
Abstract: Overfill protection device consisting of a main valve (10) and an auxiliary valve (18). This is suitable in particular for tanks to be filled with liquid, such as an LPG tank. There is a float device (22) (fig 2) that closes the auxiliary valve (18) when a desired fill level is reached. The main valve (10) consists of a piston or membrane (11) that on one side is loaded by the inlet pressure and on the other side is connected via a restriction (12) and the auxiliary valve (18) to the interior of the tank. When the auxiliary valve (18) is closed the pressure increases and an equal pressure prevails on either side of the valve body of the main valve, which leads to closure of the main valve. According to the invention the auxiliary valve is closed by means of a rod (21) attached to the float device. This closing movement is a positive pull movement. The float device is provided with a counterweight (25) (fig 2).
Patent AU-2004311518-B2 (AU)
Title: A dispensing utensil
Inventor: MOBBS KEVIN JAMES
IPC: A61J7/00
Filed: 2004-12-30
Granted: 2012-07-05
Abstract: The present invention is a dispensing utensil (10) having a conventional implement end (12) and a sealable chamber (15) containing ingredients in the handle (11). The dispensing utensil can be manufactured, filled and assembled relatively more easily and cheaply than tube-shaped dispensing utensils because of the use of a two part pliable top wall (19) and a substantially shell shaped elongate handle body.
Patent AU-2005207003-B2 (AU)
Title: Antibody specificity transfer using minimal essential binding determinants
Inventor: BALINT ROBERT F
IPC: C12N5/06
Filed: 2005-01-20
Granted: 2012-08-02
Abstract: The present invention provides methods of making antibodies having the binding specificity of a reference antibody. Antibodies generated by the methods of the inventions have at least one minimal essential binding specificity determinant from a heavy chain or light chain CDR3 from the reference antibody. The method can be used, e.g., in humanization procedures. The invention also provides libraries and antibodies made in accordance with the methods.
Patent AU-2005230862-B2 (AU)
Title: An improved process for the preparation of N-((1,2,4)triazolopyrimidin-2-yl)aryl sulfonamides
Inventor: HAMILTON CHRISTOPHER THOMAS
IPC: C07D471/04
Filed: 2005-03-24
Granted: 2010-12-23
Abstract: The N-arylsulfilimine-catalyzed coupling of aromatic sulfonyl chlorides with N-([1,2,4]triazolopyrimidin-2-yl)amines to form N-([1,2,4]triazolo-pyrimidin-2-yl)aryl sulfonamides is improved by the selection of 3-picoline or 3,5-lutidine as the base.
Patent AU-2005244456-B2 (AU)
Title: Travel pack
Inventor: ANDREW MONTGOMERY
IPC: A45F3/04
Filed: 2005-05-13
Granted: 2011-06-23
Abstract: A soft travel pack (10) of the type constructed from fabric and having straps (12, 14) for mounting the travel pack on the back of a person carrying the travel pack, the travel pack having a hinge (28) in a wall (18) thereof such that the pack can open about the hinge (28) to define a pair of luggage-storing compartments located on opposite sides of the hinge (28). In a preferred embodiment, the travel pack includes a removable travel pod (32) which can be converted into a separate carry bag.
Patent AU-2005249056-B2 (AU)
Title: System and method for performance management in a multi-tier computing environment
Inventor: ALON AMIR
IPC: G06F11/30
Filed: 2005-03-31
Granted: 2009-07-09
Abstract: Apparatus for monitoring a selected tier in a multi-tier computing environment, the apparatus including a context agent and a dynamic tier extension, the context agent associated with the selected tier and coupled with other context agents, each of which is associated with a respective tier, the dynamic tier extension coupled with the context agent and with specific predetermined points of the selected tier, the dynamic tier extension monitoring request traffic passing through the selected tier, the monitored request traffic including at least one entering request received at a request entry port from an adjacent tier, the dynamic tier extension identifying each request in the monitored request traffic and sending at least a request identifier to the context agent, the context agent also receiving information relating to the request context of the entering request from the context agent associated with the adjacent tier, the context agent associating the information relating to the request context of the entering request with the entering request, in accordance with the received request identifier.
Patent AU-2005249623-B2 (AU)
Title: Disposable breast cup set
Inventor: KREBS YVONNE
IPC: A61J9/00
Filed: 2005-05-26
Granted: 2010-09-02
Abstract: The invention relates to a disposable breast cup set which comprises a coupling element (2) to be coupled to a milk collection receptacle (1) and a breast cup connecting element (3) to be coupled to a breast cup funnel (5). The coupling element (5) and the breast cup connecting element (3) are interlinked via a tamper-evident element (4), said connection being destroyed when the coupling element (2) is for the first time separated from the breast cup connecting element (3) and preventing re-use of the set.